Company Name: |
Wuhan TCASChem Technology Co., Ltd.
|
Tel: |
027-86697669 13986148687 |
Email: |
sales@tcaschem.com |
Products Intro: |
CAS:22203-98-1 Purity:95% HPLC Package:5g,10g,25g,100g
|
Company Name: |
Wuhan Kaymke Chemical Co., Ltd.,
|
Tel: |
027-027-87342388 18086026008 |
Email: |
sales@kaymke.com |
Products Intro: |
Product Name:5-chloro-N-(3-chlorophenyl)-2-hydroxy-benzamide CAS:22203-98-1 Purity:97%min HPLC Package:5g,10g,25g,50g,100g
|
Company Name: |
Shanghai HuanChuan Industry Co.,Ltd.
|
Tel: |
021-61478794 |
Email: |
sales@hcshhai.com |
Products Intro: |
Product Name:5-chloro-N-(3-chlorophenyl)-2-hydroxy-benzaMide CAS:22203-98-1 Purity:95% Package:10g 25g
|
5-chloro-N-(3-chlorophenyl)-2-hydroxy-benzamide manufacturers
- SARS-CoV-2-IN-14
-
- $38.00 / 10mg
-
2025-05-26
- CAS:22203-98-1
- Min. Order:
- Purity: 99.3%
- Supply Ability: 10g
|
| 5-chloro-N-(3-chlorophenyl)-2-hydroxy-benzamide Basic information |
| 5-chloro-N-(3-chlorophenyl)-2-hydroxy-benzamide Chemical Properties |
form | Solid | color | White to off-white |
| 5-chloro-N-(3-chlorophenyl)-2-hydroxy-benzamide Usage And Synthesis |
Uses | SARS-CoV-2-IN-14 (compound 6) is a potent inhibitor of SARS-CoV-2 with an IC50 of 0.39 μM. SARS-CoV-2-IN-14 is a niclosamide analogue. SARS-CoV-2-IN-14 contains higher stability in human plasma and liver S9 enzymes assay than niclosamide, which can improve bioavailability and half-life when administered orally[1]. | References | [1] Juang YP, et al. Design, synthesis and biological evaluations of niclosamide analogues against SARS-CoV-2. Eur J Med Chem. 2022 May 5;235:114295. DOI:10.1016/j.ejmech.2022.114295 |
| 5-chloro-N-(3-chlorophenyl)-2-hydroxy-benzamide Preparation Products And Raw materials |
|